vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and International General Insurance Holdings Ltd. (IGIC). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($608.1M vs $403.8M, roughly 1.5× International General Insurance Holdings Ltd.).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
China Taiping Insurance Holdings Company Limited (CTIH) formerly China Insurance International Holdings Company Limited (CIIH), is a Chinese insurance conglomerate. The company has strong Chinese Central Government background despite being incorporated in Hong Kong. It is considered as a red chip company.
HIMS vs IGIC — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $608.1M | $403.8M |
| Net Profit | — | $105.1M |
| Gross Margin | 65.2% | — |
| Operating Margin | 21.9% | — |
| Net Margin | — | 26.0% |
| Revenue YoY | 3.8% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.40 | $2.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $608.1M | — | ||
| Q4 25 | $617.8M | — | ||
| Q3 25 | $599.0M | $403.8M | ||
| Q2 25 | $544.8M | $261.9M | ||
| Q1 25 | $586.0M | — | ||
| Q4 24 | $481.1M | — | ||
| Q3 24 | $401.6M | $369.6M | ||
| Q2 24 | $315.6M | $265.8M |
| Q1 26 | — | — | ||
| Q4 25 | $20.6M | — | ||
| Q3 25 | $15.8M | $105.1M | ||
| Q2 25 | $42.5M | $61.4M | ||
| Q1 25 | $49.5M | — | ||
| Q4 24 | $26.0M | — | ||
| Q3 24 | $75.6M | $-134.4M | ||
| Q2 24 | $13.3M | $70.7M |
| Q1 26 | 65.2% | — | ||
| Q4 25 | 71.9% | — | ||
| Q3 25 | 73.8% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 73.5% | — | ||
| Q4 24 | 76.8% | — | ||
| Q3 24 | 79.2% | — | ||
| Q2 24 | 81.3% | — |
| Q1 26 | 21.9% | — | ||
| Q4 25 | 1.5% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 4.9% | 24.2% | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 3.5% | -73.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.3% | — | ||
| Q3 25 | 2.6% | 26.0% | ||
| Q2 25 | 7.8% | 23.5% | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 18.8% | -36.4% | ||
| Q2 24 | 4.2% | 26.6% |
| Q1 26 | $-0.40 | — | ||
| Q4 25 | $0.08 | — | ||
| Q3 25 | $0.06 | $2.31 | ||
| Q2 25 | $0.17 | $1.36 | ||
| Q1 25 | $0.20 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.32 | $1.82 | ||
| Q2 24 | $0.06 | $1.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $222.3M | $244.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $446.2M | $654.8M |
| Total Assets | $2.3B | $2.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $222.3M | — | ||
| Q4 25 | $228.6M | — | ||
| Q3 25 | $345.8M | $244.7M | ||
| Q2 25 | $1.1B | $164.8M | ||
| Q1 25 | $273.7M | — | ||
| Q4 24 | $220.6M | — | ||
| Q3 24 | $165.5M | $219.2M | ||
| Q2 24 | $129.3M | $237.3M |
| Q1 26 | $446.2M | — | ||
| Q4 25 | $540.9M | — | ||
| Q3 25 | $581.0M | $654.8M | ||
| Q2 25 | $562.7M | $662.3M | ||
| Q1 25 | $549.3M | — | ||
| Q4 24 | $476.7M | — | ||
| Q3 24 | $440.1M | $540.5M | ||
| Q2 24 | $362.0M | $588.2M |
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $2.0B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $891.7M | — | ||
| Q4 24 | $707.5M | — | ||
| Q3 24 | $602.3M | $1.8B | ||
| Q2 24 | $480.5M | $2.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $89.4M | — |
| Free Cash FlowOCF − Capex | $53.0M | — |
| FCF MarginFCF / Revenue | 8.7% | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $60.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $89.4M | — | ||
| Q4 25 | $61.3M | — | ||
| Q3 25 | $148.7M | — | ||
| Q2 25 | $-19.1M | $27.2M | ||
| Q1 25 | $109.1M | — | ||
| Q4 24 | $86.4M | — | ||
| Q3 24 | $85.3M | — | ||
| Q2 24 | $53.6M | $120.7M |
| Q1 26 | $53.0M | — | ||
| Q4 25 | $-2.5M | — | ||
| Q3 25 | $79.3M | — | ||
| Q2 25 | $-69.5M | $26.8M | ||
| Q1 25 | $50.1M | — | ||
| Q4 24 | $59.5M | — | ||
| Q3 24 | $79.4M | — | ||
| Q2 24 | $47.6M | $119.8M |
| Q1 26 | 8.7% | — | ||
| Q4 25 | -0.4% | — | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | -12.8% | 10.2% | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | 19.8% | — | ||
| Q2 24 | 15.1% | 45.1% |
| Q1 26 | — | — | ||
| Q4 25 | 10.3% | — | ||
| Q3 25 | 11.6% | — | ||
| Q2 25 | 9.3% | 0.2% | ||
| Q1 25 | 10.1% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.9% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.98× | — | ||
| Q3 25 | 9.43× | — | ||
| Q2 25 | -0.45× | 0.44× | ||
| Q1 25 | 2.20× | — | ||
| Q4 24 | 3.32× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 4.03× | 1.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIMS
| United States Revenue | $529.9M | 87% |
| Rest of the World Revenue | $78.2M | 13% |
IGIC
Segment breakdown not available.
